| 000 | 01085 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517231305.0 | ||
| 264 | 0 | _c20191031 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1878-0938 | ||
| 024 | 7 |
_a10.1016/j.carrev.2018.07.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodriguez, Alfredo E | |
| 245 | 0 | 0 |
_aThe ORBITA trial: Why is it not the last nail for coronary angioplasty in stable angina patients? _h[electronic resource] |
| 260 |
_bCardiovascular revascularization medicine : including molecular interventions _c01 2019 |
||
| 300 |
_a80-81 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAngina, Stable |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMyocardial Revascularization |
| 650 | 0 | 4 | _aPercutaneous Coronary Intervention |
| 773 | 0 |
_tCardiovascular revascularization medicine : including molecular interventions _gvol. 20 _gno. 1 _gp. 80-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.carrev.2018.07.018 _zAvailable from publisher's website |
| 999 |
_c28679281 _d28679281 |
||